These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3244715)

  • 21. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine.
    Long G; Marsh HM
    Anaesth Intensive Care; 1981 May; 9(2):144-6. PubMed ID: 7258611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protection of primates against soman poisoning by pretreatment with pyridostigmine.
    Dirnhuber P; French MC; Green DM; Leadbeater L; Stratton JA
    J Pharm Pharmacol; 1979 May; 31(5):295-9. PubMed ID: 37298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-Aminopyridine potentiates neostigmine and pyridostigmine in man.
    Miller RD; Booij LH; Agoston S; Crul JF
    Anesthesiology; 1979 May; 50(5):416-20. PubMed ID: 453559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats.
    Soares PP; da Nóbrega AC; Ushizima MR; Irigoyen MC
    Auton Neurosci; 2004 Jun; 113(1-2):24-31. PubMed ID: 15296792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bradycardia produced by pyridostigmine and physostigmine.
    Stein RD; Backman SB; Collier B; Polosa C
    Can J Anaesth; 1997 Dec; 44(12):1286-92. PubMed ID: 9429048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats.
    Anderson DR; Harris LW; Woodard CL; Lennox WJ
    Drug Chem Toxicol; 1992; 15(4):285-94. PubMed ID: 1459041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparison of the two anticholinergic agents atropine and glycopyrrolate during antagonism of a muscle relaxation with pyridostigmine].
    Braun GG; Schywalsky M; Wölfel L; Müller H; Danner U; Albert R
    Anaesthesiol Reanim; 1993; 18(5):120-2, 125-7. PubMed ID: 8280339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
    Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
    Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute behavioral toxicity of pyridostigmine or soman in primates.
    Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.
    Sabino JP; da Silva CA; Giusti H; Glass ML; Salgado HC; Fazan R
    Auton Neurosci; 2013 Dec; 179(1-2):43-8. PubMed ID: 23911533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease.
    Castro RR; Porphirio G; Serra SM; Nóbrega AC
    Braz J Med Biol Res; 2002 Jun; 35(6):685-9. PubMed ID: 12045833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of atropine on the QT interval and T-wave amplitude in healthy volunteers.
    Annila P; Yli-Hankala A; Lindgren L
    Br J Anaesth; 1993 Nov; 71(5):736-7. PubMed ID: 8251290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
    Castro RRT; Porphirio G; Xavier SS; Moraes RS; Ferlin EL; Ribeiro JP; da Nóbrega ACL
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28715142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of topical fenthion on blood cholinesterase and vagal tone in dogs.
    Dellinger J; Mostrom M
    Vet Hum Toxicol; 1988 Jun; 30(3):229-34. PubMed ID: 3388751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats.
    Chaney LA; Rockhold RW; Hume AS
    Int J Toxicol; 2002; 21(4):287-300. PubMed ID: 12171630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcholine-Atropine Interactions: Paradoxical Effects on Atrial Fibrillation Inducibility.
    Liu Y; Scherlag BJ; Fan Y; Xia W; Huang H; Po SS
    J Cardiovasc Pharmacol; 2017 Jun; 69(6):369-373. PubMed ID: 28328743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
    von Bredow JD; Adams NL; Groff WA; Vick JA
    Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of atropine and glycopyrrolate in a mixture with pyridostigmine for the antagonism of neuromuscular block.
    Mirakhur RK; Briggs LP; Clarke RS; Dundee JW; Johnston HM
    Br J Anaesth; 1981 Dec; 53(12):1315-20. PubMed ID: 7317249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.